Key opinion leaders previously interviewed by GlobalData noted the need for more data on current RSV vaccines and their use ...

Viruses like the flu, COVID and RSV tend to surge during the winter so NBC medical reporter Dr. Akshay Syal joins TODAY to ...

Babies can be safely administered antibody protection against respiratory syncytial virus after birth even if their moms had ...

Respiratory syncytial virus (RSV) can be life-threatening, but there are new treatments to prevent and treat the disease.

By Dennis Thompson HealthDay ReporterMONDAY, Oct. 20, 2025 (HealthDay News) — Babies can be safely administered antibody ...

SHELTON, CONNECTICUT / ACCESS Newswire / October 22, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer:NNVC) (the “Company”), announced that its clinical lead drug NV-387 has shown ...

GlaxoSmithKline (($GSK)) announced an update on their ongoing clinical study. Study Overview: GlaxoSmithKline (GSK) is conducting a Phase 3 ...

A mother is sharing the devastation she felt watching her newborn son develop respiratory syncytial virus (RSV) and urging ...

CAPE GIRARDEAU, Mo. (KFVS) - The air is finally getting that crisp fall feeling in the Heartland. It signals a change in ...

Flu, COVID-19, the common cold and RSV have similarities, but they differ in their severity, contagiousness and symptoms.

Compared with placebo, single-dose clesrovimab 105 mg reduced the risk for RSV-associated LRI and hospitalization in healthy infants.

Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) on Monday released topline data from RSVHR Phase 2b study of zelicapavir in outpatient adults with acute respiratory syncytial virus (RSV) infection who are ...